首页> 美国卫生研究院文献>Molecules >Potential Mechanism of Action of 3′-Demethoxy-6-O-demethyl-isoguaiacin on Methicillin Resistant Staphylococcus aureus
【2h】

Potential Mechanism of Action of 3′-Demethoxy-6-O-demethyl-isoguaiacin on Methicillin Resistant Staphylococcus aureus

机译:3-去甲氧基-6-O-去甲基-异愈创霉素对耐甲氧西林金黄色葡萄球菌的作用机理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bacterial infections represent one of the main threats to global public health. One of the major causative agents associated with high morbidity and mortality infections in hospitals worldwide is methicillin-resistant Staphylococcus aureus. Therefore, there is a need to develop new antibacterial agents to treat these infections, and natural products are a rich source of them. In previous studies, we reported that lignan 3′-demethoxy-6-O-demethylisoguaiacin, isolated and characterized from Larrea tridentate, showed the best activity towards methicillin-resistant S. aureus. Thus, the aim of this study was to determine the potential molecular mechanism of the antibacterial activity of 3′-demethoxy-6-O-demethylisoguaiacin against methicillin-resistant S. aureus using microarray technology. Results of microarray genome expression were validated by real-time polymerase chain reaction (RT-PCR). The genetic profile expression results showed that lignan 3′-demethoxy-6-O-demethylisoguaiacin had activity on cell membrane affecting proteins of the ATP-binding cassette (ABC) transport system causing bacteria death. This molecular mechanism is not present in any antibacterial commercial drug and could be a new target for the development of novel antibacterial agents.
机译:细菌感染是全球公共卫生的主要威胁之一。在世界范围内,与高发病率和高死亡率感染相关的主要病因之一是耐甲氧西林的金黄色葡萄球菌。因此,需要开发新的抗菌剂来治疗这些感染,并且天然产物是它们的丰富来源。在以前的研究中,我们报道了从Larrea tridentate分离并鉴定的木脂素3'-demethoxy-6-O-demethylisoguaiacin对耐甲氧西林的金黄色葡萄球菌显示出最佳活性。因此,本研究的目的是使用微阵列技术确定3'-脱甲氧基-6-O-脱甲基异愈创霉素对耐甲氧西林金黄色葡萄球菌的抗菌活性的潜在分子机制。通过实时聚合酶链反应(RT-PCR)验证了微阵列基因组表达的结果。遗传图谱表达结果表明,木脂素3'-demethoxy-6-O-demethylisoguaiacin对影响ATP结合盒(ABC)转运系统蛋白的细胞膜具有活性,从而导致细菌死亡。这种分子机制在任何抗菌商品中都不存在,并且可能成为开发新型抗菌剂的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号